NCT06737354 Safety and Efficacy Study of IVB103 Injection in Subjects With Neovascular (Wet) Agerelated Macular Degeneration (nAMD). Status ENROLLING_BY_INVITATION Phase PHASE1
NCT06672536 Multicenter, Phase I/II Study to Evaluate the Safety, Tolerability, PK and Efficacy of SCT520FF in Patients With nAMD Status RECRUITING Phase PHASE1/PHASE2
NCT05562947 A Study of the Efficacy, Safety, and Pharmacokinetics (PK) of the Port Delivery System With Ranibizumab (PDS) in Chinese Participants With Neovascular Age-related Macular Degeneration (nAMD) Status RECRUITING Phase PHASE3
NCT05407636 Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD Status RECRUITING Phase PHASE3
NCT05210803 Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD Status ENROLLING_BY_INVITATION Phase N/A
NCT04704921 Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3